---

Background: Patients with type 2 diabetes mellitus are more prone to depression. Prevalence of depression in the Iranian results of studies is different. Therefore, the present study aims to study the prevalence of depression in Iranian patients with type II diabetes mellitus.

Methods: This study is a systematic review based on PRISMA guideline for systematic reviews and meta-analyses study. Literature searches of, Scopus, MEDLINE, PubMed, Science Direct, Cochrane, EMBASE, Web of Science, Springer, Online Library Wiley, Google Scholar search engine and Iranians database for publications in Persian and English were conducted up to December 2015. Searches were performed by two researchers independently using standard keywords. Reviewers extracted data and assessed methodological quality in duplicate.  Meta-analysis was performed using STATA, version 11.1 to combine data through Random Effects Model.

Results: Sixteen studies and 3,284 subjects with a mean age of 48.6 years were included in the analysis.  The prevalence of depression in Iranian patients with type II diabetes was estimated 54.8% (95% CI: 43.5- 66.1). This range for males and females were calculated 32.2 %( 95% CI: 16.3-48.1) and 60% (95% CI: 46.4-73.7), respectively. The highest prevalence of depression was in the center of Iran (60%) and the lowest rate was in the west of Iran (38%).

Conclusion: Regarding to high prevalence of depression in patients with type II diabetes, Implementation of screening program for psychiatric disorders, especially depression as well as conducted psychiatric consultation routinely for diagnosis and treatment of depression in these patients it seems necessary.

---

Background: Effect of mobile text message on blood glucose (HbA1c) control in providing type 2 diabetes care (diabetes mellitus non insulin dependent).

Methods: The present study is a systematic review with meta-analysis. A search of the most important electronic medical databases of medical resources from December 1992 to January 2017 in a systematic manner, including: CRD, Ovid Medline, PubMed, Cochrane Library, and moreover, by referring to the resources found in the articles and manual search on the site. Related to this technology and, if necessary, contacting experts. All randomized clinical trials and cohort studies were reviewed.
Results: Participants included nine studies (818), all randomized clinical trials, and quality assessment. The average decrease in Mobile SMS Services users compared to the control group (SMD-0.324, 95% CI, -0.526 to -0.121; I2 = 51.0). The analysis of subgroups showed that young patients are more likely to use diabetes programs, and the size of the effect increases with short intervals of interventions and the size of large samples.
Conclusion: Mobile SMS services may be considered as an effective component for helping control glycosylated hemoglobin and as a side intervention for the care of patients with type 2 diabetes.